Induction of Galphaq-specific antisense RNA in vivo causes increased body mass and hyperadiposity

J Biol Chem. 1997 Feb 14;272(7):4335-41. doi: 10.1074/jbc.272.7.4335.

Abstract

Transgenic BDF-1 mice harboring an inducible, tissue-specific transgene for RNA antisense to Galphaq provide a model in which to study a loss-of-function mutant of Galphaq in vivo. Galphaq deficiency induced in liver and white adipose tissue at birth produced increased body mass and hyperadiposity within 5 weeks of birth that persisted throughout adult life. Galphaq-deficient adipocytes display reduced lipolytic responses, shown to reflect a newly discovered, alpha1-adrenergic regulation of lipolysis. This alpha1-adrenergic response via phosphoinositide hydrolysis and activation of protein kinase C is lacking in the Galphaq loss-of-function mutants in vivo and provides a basis for the increased fat accumulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adipose Tissue / cytology
  • Adipose Tissue / metabolism*
  • Animals
  • Body Weight / genetics*
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Diglycerides / metabolism
  • Enzyme Activation
  • Female
  • GTP-Binding Proteins / genetics*
  • Inositol 1,4,5-Trisphosphate / metabolism
  • Lipolysis
  • Male
  • Mice
  • Mice, Transgenic
  • Phosphoenolpyruvate Carboxykinase (GTP) / genetics
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • RNA, Antisense / biosynthesis*
  • Type C Phospholipases / metabolism

Substances

  • Diglycerides
  • RNA, Antisense
  • Inositol 1,4,5-Trisphosphate
  • Cyclic AMP
  • Protein Kinase C
  • Type C Phospholipases
  • GTP-Binding Proteins
  • Phosphoenolpyruvate Carboxykinase (GTP)